Trial Profile
Analysis of iron metabolism during Ledipasvir/Sofosbuvir treatment in patients with genotype 1 hepatitis C virus infection and compensated cirrhosis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 20 Apr 2019
Price :
$35
*
At a glance
- Drugs Ledipasvir/sofosbuvir (Primary)
- Indications Hepatitis C; Liver cirrhosis
- Focus Therapeutic Use
- 15 Feb 2018 Status changed from recruiting to completed.
- 16 Aug 2016 Status changed from not yet recruiting to recruiting.
- 31 May 2016 New trial record